The implementation of beta blockers in clinical practice is feasible and could be accelerated. These drugs are associated with a lower mortality and reduced hospital admission rates, not only in clinical trials but also in the normal clinical setting.
Faı̈ez Zannad, Wendy Gattis Stough, Patrick Rossignol, Johann Bauersachs, John J.V. McMurray, Karl Swedberg, Allan D. Struthers, A.A. Voors, Luís M. Ruilope, G. Bakris, Christopher M. O’Connor, Mihai Gheorghiade, Robert J. Mentz, A Cohen-Solal, Aldo Maggioni, Farzin Beygui, Gerasimos Filippatos, Ziad A. Massy, Atul Pathak, Ileana L. Piña, Hani N. Sabbah, Domenic A. Sica, ,
Discussion(0)
No comments yet. Be the first to comment.